This observational study is looking at how the Minder System, an implanted device that records brain activity (EEGs), helps doctors make treatment decisions for people with epilepsy. It's for individuals whose seizures aren't well-controlled by standard methods. The Minder System is already approved by the FDA and is not an experimental device. Researchers want to see how treatment changes based on information from the Minder System affect participants' overall well-being over two years. To join, you must have previously completed the DETECT study, received the Minder System, and still have it implanted. The study aims to enroll 210 participants aged 18 to 75 years. The current recruitment status is unclear.

Study design

This is an observational study, meaning researchers will watch and collect information without providing a new treatment. It plans to enroll 210 participants.

What's involved

Participants will be followed for two years to assess changes in their treatment and well-being. Specific visits or procedures are not detailed.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for two years to evaluate the Minder System's impact on treatment decisions.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.